Ruxolitinib as a therapy choice for refractory pruritus in a patient with essential thrombocythemia with CALR mutation
<p>Refractory pruritus associated with Essential Thrombocythemia (ET) is rare. Herein, we present the first report of resistant pruritus responsive to ruxolitinib in an ET patient with a calreticulin mutation.</p>
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Global Journal of Medical and Clinical Case Reports - Peertechz Publications,
2023-01-25.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|